This brand name is authorized in Israel.
The drug SULFACID contains one active pharmaceutical ingredient (API):
1
|
UNII
4NRT660KJQ - SULFACETAMIDE SODIUM
|
|
The sulfonamides are bacteriostatic agents and the spectrum of activity is similar for all. Sulfonamides inhibit bacterial synthesis of dihydrofolic acid by preventing the condensation of the pteridine with aminobenzoic acid through competitive inhibition of the enzyme dihydropteroate synthetase. |
|
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC Group | Classification | |
|---|---|---|
| S01AB04 | Sulfacetamide | S Sensory organs → S01 Ophthalmologicals → S01A Antiinfectives → S01AB Sulfonamides |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| IL | מִשְׂרַד הַבְּרִיאוּת | 1834 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.